IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 11

Issue Published : 118

Article Submitted : 21653

Article Published : 8541

Total Authors : 22459

Total Reviewer : 811

Total Countries : 159

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Exploring the Potential of Ganoderma Lucidum in Cancer Treatment: Benefits and Limitation of its Biological Actions
Authors Name: Aditya Ranjan Jena , J Anbu , S Deepika , Yuvarani K R , M Srujana
Download E-Certificate: Download
Author Reg. ID:
IJRTI_205334
Published Paper Id: IJRTI2507091
Published In: Volume 10 Issue 7, July-2025
DOI: https://doi.org/10.56975/ijrti.v10i7.205334
Abstract: Ganoderma lucidum, a traditional Asian medicine with a long history, has been found to be a potential candidate in complementary cancer therapy. This review thoroughly discusses the anticancer potential of G. lucidum based on its bioactive compounds, mainly polysaccharides and triterpenoids, and their mechanistic functions. The mushroom has multifunctional activities, such as immune system modulation, apoptosis induction, cancer cell proliferation inhibition, metastasis and angiogenesis suppression, and oxidative stress regulation. Polysaccharides activate immune cells and cytokine production, which increases the host's antitumor activity. Triterpenoids, especially ganoderic acids, have direct cytotoxicity and modulate pathways like PI3K/Akt and MAPK. G. lucidum exerts synergistic action with chemotherapy and radiotherapy, enhancing the efficacy of treatments and minimizing side effects such as nausea and fatigue. In spite of its therapeutic potential, limitations including low bioavailability, unstandardized extract, and insufficient high-quality clinical trials limit its clinical use in the mainstream. Future studies must be directed towards nanoparticle-based drug delivery systems and standardized formulations to enhance efficacy and predictability. This review underscores the great potential of G. lucidum as both a treatment and prophylactic agent in oncology, which deserves further investigation and clinical testing.
Keywords: Key-words: Ganoderma lucidum, cancer therapy, triterpenoids, PI3K/Akt
Cite Article: "Exploring the Potential of Ganoderma Lucidum in Cancer Treatment: Benefits and Limitation of its Biological Actions", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 7, page no.a837-a851, July-2025, Available :http://www.ijrti.org/papers/IJRTI2507091.pdf
Downloads: 000391
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2507091
Registration ID:205334
Published In: Volume 10 Issue 7, July-2025
DOI (Digital Object Identifier): https://doi.org/10.56975/ijrti.v10i7.205334
Page No: a837-a851
Country: Bengaluru, Karnataka, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2507091
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2507091
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner